Skip to main content
Clinical Trials/NL-OMON26240
NL-OMON26240
Recruiting
N/A

A multicenter, prospective feasibility follow-up study to evaluate a fully covered stent with new antimigration properties for the palliation of malignant dysphagia: HANARO study.

niversity Medical Center Utrecht (UMCU), Departement of Gastronenterology and Hepatology0 sites40 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Esophageal cancer, Dysphagia, Palliation, Migration, Stent
Sponsor
niversity Medical Center Utrecht (UMCU), Departement of Gastronenterology and Hepatology
Enrollment
40
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
niversity Medical Center Utrecht (UMCU), Departement of Gastronenterology and Hepatology

Eligibility Criteria

Inclusion Criteria

  • 1\. Inoperable malignant obstruction of the esophagus or esophagogastric junction caused by esophageal or cardia carcinoma or extrinsic malignant compression. A tumor is considered inoperable if the patient has local tumor infiltration in the surrounding organs, distant metastases or a poor general health due to serious concomitant disease, OR;
  • 2\. Recurrent dysphagia after prior radiation with curative or palliative intent for esophageal or gastric cardia cancer;

Exclusion Criteria

  • 1\. Evidence of tumor growth within 2 cm of the upper esophageal sphincter;
  • 2\. A tumor covering \< 50% of the circumference;

Outcomes

Primary Outcomes

Not specified

Similar Trials